These press releases are intended for business journalists and analysts/investors. Please note that these releases may not have been issued in every market in which GSK operates.
16 May 2012
GlaxoSmithKline completes transaction to increase its ownership in Theravance
15 May 2012
GlaxoSmithKline to fully acquire Cellzome for £61 million
14 May 2012
GSK statement on BBC Panorama broadcast: ‘the truth about tax’

25 Apr 2012: Download GSK Q1 results 2012 (PDF)

30 Jan 2012: GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020
Read a selection of publications featuring our CEO Sir Andrew Witty
View and download our results announcement and view CFO interview.
We aim to create the best product pipeline in the industry for the benefit of patients, consumers and society.
Our R&D organisation measures productivity by the number and innovation of the products it creates, and also by the commercial value of the products.
More about our product pipeline